Vanda Pharmaceuticals (VNDA) Finished Goods (2014 - 2018)

Vanda Pharmaceuticals has reported Finished Goods for 5 years, with the latest figure at $1.0 million in Q1 2018.

• Quarterly Finished Goods rose 31.98% year-over-year to $1.0 million in Q1 2018, while the trailing twelve-month figure through Mar 2018 was $1.0 million (up 31.98% YoY) and the FY2017 annual result came in at $760000.0, changed 0.26% from the prior year.
• Finished Goods rose to $1.0 million in Q1 2018 per VNDA's latest filing, from $760000.0 in the prior quarter.
• Over five years, Finished Goods peaked at $3.4 million in Q4 2014 and troughed at $611000.0 in Q2 2017.
• A 5-year average of $1.5 million and a median of $941000.0 in 2014 frame the typical range for Finished Goods.
• The widest YoY moves for Finished Goods: up 181.19% in 2015, down 61.87% in 2015.
• Over 5 years, Finished Goods stood at $3.4 million in 2014, then plunged by 61.87% to $1.3 million in 2015, then sank by 41.11% to $762000.0 in 2016, then dropped by 0.26% to $760000.0 in 2017, then jumped by 33.03% to $1.0 million in 2018.
• According to Business Quant data, Finished Goods over the past three periods registered $1.0 million, $760000.0, and $858000.0 for Q1 2018, Q4 2017, and Q3 2017 respectively.